Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Vargas, Noel
NCT05161195 / 2021-005184-42: Roll-over Study to Allow Continued Access to Ribociclib	Recruiting	4	137	Europe, Japan, US, RoW	Ribociclib, Letrozole, Anastrozole, Goserelin, Tamoxifen, Fulvestrant	Novartis Pharmaceuticals, Novartis Pharma AG	Metastatic Breast Cancer	02/30	03/30
Wise, Amanda
KontRASt-02, NCT05132075 / 2021-002605-10: Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer	Active, not recruiting	3	95	Europe, Canada, US, RoW	JDQ443, docetaxel	Novartis Pharmaceuticals, Novartis Pharma AG	Non-Small Cell Lung Cancer	09/24	05/25